These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3906398)

  • 1. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J; Banihashemi MA; Ghezlou M; Afshariani R; Salari S; Moini M; Sagheb MM
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U; Ludvik B; Gisinger C; Schernthaner G
    Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP; Raskovic M; Schimke E
    Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R; Malý J; Simková R
    Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
    Matsubara M; Taguma Y; Saito T; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):411-6. PubMed ID: 1635286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the ACE-inhibitor captopril on the blood pressure and kidney function of patients with essential and renal hypertension].
    Jansa U; Stein G; Günther K
    Z Gesamte Inn Med; 1991 Dec; 46(17):642-7. PubMed ID: 1776307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
    N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
    Tajiri Y; Umeda F; Inoguchi T; Kunisaki M; Nawata H; Ninomiya H; Asano T
    Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
    Holländer E
    Orv Hetil; 1987 Apr; 128(17):893-5. PubMed ID: 3295665
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A; Janghorbani M; Rezvanian H; Aminian T; Gharavi M; Amini M
    Nephron Clin Pract; 2005; 99(3):c73-7. PubMed ID: 15665549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of captopril on heavy proteinuria in patients with various glomerular diseases.
    Han DS; Ha SK; Choi KH; Lee HY
    Yonsei Med J; 1992 Sep; 33(3):232-9. PubMed ID: 1292247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
    Boratyńska M; Mazanowska O; Szewczyk Z; Czyz W
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1090-2. PubMed ID: 1305732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.